Episode #28: November 2020 – Compounding, Controlled Substances, and Legislative Agenda

Following the November 17 Board of Pharmacy meeting, IPA's Director of Public Affairs, Casey Ficek, and Sue Mears from the Board of Pharmacy discuss board action on the FDA’s memorandum of understanding regarding compounding, proposed rules impacting controlled substances and the PMP, and the Board’s legislative agenda.